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The integrin a6p4 is a member of the integrin family of 
adhesion receptors. The integrin a6p4 is preferentially ex-
pressed in stratified squamous epithelia, where it is localized 
in hemidesmosomes. A reduced number of rudimentary he-
midesmosomes is often found in skin from patients with 
junctional epidermolysis bullosa GEB). In this study we have 
investigated the expression of a6p4 in skin specimens of 
patients with junctional (one non-lethal, two lethal) and dys-
trophic (two) epidermolysis bullosa, using immunofluores-
cent (IF) staining with five different monoclonal antibodies 
against the a6 and P4 subunits. The intensity ofIF staining of 
the integrin a6p4 and bullous pemphigoid antigen (BPA) 
was unreduced along the epidermal basement membrane 
zone (EBMZ) of all EB patients, compared to that in skin of 
healthy human controls. However, in the skin of two pa-
unctional epidermolysis bullosa OEB) represents a subgroup 
of hereditary mechanobullous diseases in which there is 
always a cleavage plane in the lamina lucida of the epidermal 
basement membrane zone (EBMZ). Most patients withJEB 
have ultrastructurally defective hemidesmosomes, e.g., ab-
sent sub-basal densa plates and rudimentary attachment 
plaques [1]. The antigenicity of the EBMZ is altered in pa-
tients withJEB: the lamina lucida antigen BM-600/nicein identi-
fied by the antibodies AA3 [2] and GB3 [3] is reduced or absent. JEB 
patients also do not express the antigen identified by monoclonal 
antibody(ies) (MoAb) 19-DEJ-l, which is associated with the he-
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Abbreviations: 
BPA: bullous pemphigoid antigen 
BMZ: basement membrane zone 
Casbl: cascade blue 
EB: epidermolysis bullosa 
EBMZ: epidermal basement membrane zone 
EM: electron microscopy 
FITC: fluorescein isothiocyanate 
HRP: horse radish peroxidase 
IF: immunofluorescence 
IBM: immunoelectron microscopy 
IgG: immunoglobulin G 
JEB: junctional epidermolysis bullosa 
MoAb: monoclonal antibody(ies) 
PBS: phosphate-buffered saline 
PLP: periodate-lysine-paraformaldehyde 
tients with lethal (Herlitz) lEB, who did not express GB3, IF 
staining of integrin a6p4 and BPA showed a "stitchy" dis-
continuous linear pattern along the EBMZ with interrup-
tions at the borders of adjoining basal keratinocytes. The 
same results were obtained by immunoelectron microscopy. 
They corresponded with freeze-induced partial cell detach-
ment from the basement membrane at the ultimate baso-Ia-
teral edge of the basal keratinocytes in lethal lEB skin. The 
basallamellipodia at that location almost completely lacked 
to no filaments and hemidesmosomes. Furthermore, in lEB 
there was a split between the intra- and extracellular epitopes 
of the integrin a6p4 receptor, whereas the integrin remains 
intact in salt-split skin. This suggests that the defect is in 
a6p4 itself or perhaps its ligand. ] Invest Dermatol 99:489-
496,1992 
midesmosomal anchoring filament complex [4]. The bullous pem-
phigoid antigen (BPA), which is exclusively localized in the plaque 
of the hemidesmosome [5,6], is normally expressed inJEB [7,8] and 
no gross abnormalities of the 230-kD BP A gene can be detected by 
Southern blot analysis in these patients [9]. It is still unknown which 
antigenic determinant of the hemidesmosomes is defective in pa-
tients with JEB. A recently recognized member of the integrin 
superfamily of adhesion receptors, the integrin a6fJ4 [10,11] might 
be a candidate. 
Integrins are a superfamily of cell-surface receptors [12], consist-
ing of noncovalently linked heterodimers of a and fJ subunits, 
which mediate cell-cell and cell-matrix adhesion. At least 13 a [13] 
chains and sevenfJ chains [14] have been recognized, of which only 
a6fJ4 is exclusively associated with keratinocyte-basement mem-
brane adhesion [15]. The evidence that integrin a6fJ4 is preferen-
tially located in hemidesmosomes was recently independently ob-
tained by several laboratories and was based on immunoelectron 
microscopy (IEM) on cultured epithelial cells [16,17] and epithelial 
tissues [15,18 -20] using antibodies against the a6 and fJ4 subunits. 
In support of this, it was shown that a6fJ4 co-distributes with the 
hemidesmosome component 230-kD BPA [15,17]. Integrin a6fJ4 
polarizes within 12 h to the basal surface of cultured keratinocytes 
[21], which appears to be calcium dependent [22]. Anti-fJ4 antibod-
ies strongly inhibit keratinocyte adhesion to various substrates 
[21,22]. Recently, Jones et al demonstrated that anti-a6fJ4 antibod-
ies prevent hemidesmosome assembly and alter the IF pattern of 
230-kDa BPA (and probably integrin a6fJ4) [19]. These studies 
suggests that the integrin a6fJ4 may act as a nucleating center for 
hemidesmosomes. 
In a previous study by Nazzaro and colleagues [23,24], a6 subunit 
(GoH3 [25]) was found to be normally present along the EBMZ in 
patients with JEB (two lethal, one non-lethal). Fine et al recently 
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Table I. Summary of the Examined MoAb 
Against Human Integrin 0:6P4 
Epitope 
MoAb Titer Host IgIsotype Subunit Localization 
450-11A 50 Mouse IgGl P4 Intracellular 
450-10D 50 Mouse IgG2a P4 Intracellular 
439-9B 50 Rat IgG2 P4 Extracellular 
450-30D 50 Mouse IgG1 a6 Extracellular 
GoH3 50 Rat IgG2a a6 Extracellular 
reported in an abstract that the expression of the integrin 0:6P4 is 
unreduced in each of over 60 JEB patients [26]. However, no details 
are available concerning the spatial distribution of 0:6P4 in relation 
to BPA, GB3, and laminin inJEB skin. 
In this study we report on the expression of both the 0:6 and p4 
subunits, using five MoAb against different intra- and extracellular 
epitopes of the integrin 0:6P4 complex in patients with junctional 
and dystrophic epidermolysis bullosa (EB). 
MATERIALS AND METHODS 
Patients Five patients with EB were studied: three with JEB and 
two with dystrophic EB. The three patients with JEB included a 
2-month old female (patient 1) and a 6-month old male patient 
(patient 2) suffering from the lethal (Herlitz) variant, and a 39-year 
old male patient (patient 3) with the non-lethal variant (synonym: 
generalized atrophic benign EB). The two dystrophic EB patients 
included a 6-month old female patient (patient 4) with the domi-
nant (Cockayne-Touraine) variant, and a 7-year old female patient 
(patient 5) with the recessive generalized mitis (non-mutilating) 
variant. The case histories of patients 1 and 5 have been published 
[27,28]. Diagnosis was established in each patient on the basis of 
clinical findings, family history, immunofluorescence mapping, 
and electron microscopy (EM). All three patients with JEB had a 
reduced number of hypoplastic hemidesmosomes lacking the sub-
basal densa plate in clinically uninvolved skin. Skin specimens of 
three healthy adults and a I-year old child served as controls. 
Skin Specimens For the IF and EM studies we used 4-mm 
punch-biopsy specimens, obtained under local anesthesia with 2% 
lidocaine from apparently uninvolved skin from the extremities of 
the EB patients. In addition, a biopsy of lesional skin was obtained. 
Skin specimens of three healthy adults and a I-year old child served 
as controls. The skin specimens were sn/LRSC, nap frozen in liquid 
nitrogen and stored at -70°C. 
For the in situ localization of integrin 0:6P4 in a model split of the 
EBMZ, we used skin tissue obtained from breast reductive surgery. 
Splitting of the EBMZ was achieved by a slightly modified incuba-
tion technique with NaCI as originally described by Scaletta et al 
[29], introduced as a tool for antigen localization by Gammon et al 
[30] . The skin specimens were incubated for 24 h in 1.0 M NaCI at 
room temperature, followed by washing for 30 min in PBS (vide 
infra), and snap frozen in liquid nitrogen. Immunofluorescence an-
tigen mapping. showed that laminin was always in the blister floor 
and the BP A in the blister roof. 
Antibodies Characteristics of the monoclonal antibodies 
(MoAb) against the integrin 0:6 and P4 subunits are summarized in 
Table 1. MoAb 450-11A, 450-10D, 439-9B, and 450-40D were 
kindly provided by Dr. S.]. Kennel [31,32]. MoAb GoH3 has been 
characterized in a previous study [25]. The GB3 marker for JEB was 
obtained through the courtesy of Dr. ].-P. Ortonne [33]. Other 
primary antibodies included polyclonal rabbit anti-laminin (Telios, 
CA) and biotinylated human IgG autoantibody against the BPA 
[34]. 
Secondary antibodies included biotinylated horse anti-mouse IgG 
(Vector Labs, CA), biotinylated goat anti-rabbit IgG (Protos Labs, 
CA), fluorescein isothiocyanate (FITC) - conjugated goat anti-rat 
immunoglobulin G (IgG) (SBA, Alabama, USA), and cascade blue 
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(Casbl)-conjugated goat anti-rabbit IgG (Molecular Probes, OR). 
The binding ofbiotinylated antibodies was visualized by incubation 
with either FITC-conjugated extra-avidin (Biomakor) or LRSC 
(lissamine rhodamine)-conJugated streptavidin Oackson ImmRes, 
PA). 
Immunofluorescence (IF) Procedures Cryosections of 4 /lm 
thickness were mounted on silane-coated slides, air dried for 30 min 
by using a fan, and stained for 30 min with the properly diluted 
primary antibodies. After three washes for 5 min each in phosphate-
buffered saline (PBS; 0.01 M; pH 7.3), the sections were incubated 
for 30 min with the appropriate FITC- or biotin-labeled secondary 
antibody. In case of biotinylated secondary antibody, the sections 
were washed again in PBS and incubated for 30 min with either 
extra-avidin/ FITC or streptavidin/LRSC conjugate. A typical tri-
ple antigen-labeling experiment (Fig IB) consisted of the follow-
ing seven incubation steps: 1) mouse IgG anti-GB3, 2) horse IgG 
anti-mouse IgG/B.io, 3) stre.f'tavidin/LRS~, 4) rat IgG a~ti~439-
9B, 5) goat Ig anti-rat IgG/FITC, 6) rabblt IgG anti-lammm, 7) 
goat Ig anti-rabbit IgG/Casbl. 
A number of control staining experiments were performed to 
ensure the specificity of double and triple antigen-labeling pro~e­
dures. These control experiments included purposely cross-reactive 
immunostaining steps that confirmed the expected "false" fluores-
cent color profiles of the basement membrane epitopes. 
Sections were mounted in PBS-glycerol (50%; pH 7.5). For pho-
tomicrography, the sections were mounted in PBS-glycerol con-
taining p-phenylenediamine (1.5 mg/ml) . 
The sections were examined with a Leitz Orthoplan microscope 
equipped with both high-pressure Xenon (XBO-75W) and Me~­
cury arc (HBO-50W), and Ploemopak unit for incident-light eXC1-
tation. For selective excitation and emission, varying combinations 
of filter blocks (Leitz/Leica) were used including the L3 block 
(green), the A2 block (blue), the TXR block (red), and a newly 
developed FITC/TXR dual-band block (Omega Optical Inc., Ver-
mont) for simultaneous green and red fluorescence. 
Photomicrographs were made with the Vario Orthomat-2, using 
Fujichrome 400 ASA color reversal film. Photomicrography of mul-
tiple-stained tissue sections was performed by a specially developed 
selective double- or triple-wavelength recording technique involv-
ing geometrical (optical) shift adjustment. 
Electron Microscopy Biopsies from uninvolved skin were fixed 
with 2% glutaraldehyde in 0.1 M phosphate buffer, stained with 2% 
osmium tetroxide, embedded in epon, sectioned, and counter-
stained with uranyl acetate. The ultra-thin sections were examined 
with the Agashi 002A electron microscope. 
Immunoelectron Microscopy Cryosections of 15 Ilm thick-
ness were mildly fixed for 3 min in 0.015% periodate-Iysine-para-
formaldehyde (PLP) reagent, washed in PBS and stained en bloc f?r 
30 min with 450-10D (P4) primary antibody. After washing 10 
PBS, sections were incubated for 30 min with the HRP-labeled 
rabbit anti-mouse Ig conjugate, washed again, and treated for 30 
min with the HRP-Iabeled goat anti-mouse Ig conjugate. The sec-
tions were washed, postfixed in 0.5% glutaraldehyde in phosphate 
buffer (0.1 M, pH 7.4), washed again, and developed with 0.05% 
3,3' diaminobenzidine tetrahydrochloride (DAB; Sigma) in PBS 
with 0.03% hydrogen peroxide. The sections were further pro-
cessed for electron microscopy as described above, omitting the step 
for counterstaining. I 
RESULTS 
IF of Normal Human Skin The results of analysis of 0:6p4 
expression in skin tissue sections by immunofluorescence are listed 
in Table II. In normal human skin, staining with MoAb against 
integrin 0:6 and P4 subunits produced a continuous linear fluo~es­
cence pattern along the EBMZ (Fig lA). In addition, MoAb agalOst 
the extracellular epitopes of the 0:6 (450-30D, GoH3) and p4 sub-
unit (439-9B) focally stained the lateral and apical borders of basal 
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Figure 1. IF staining of cryosections of (A) intact control skin, and (B) salt-split control skin from a healthy person. (A) Single IF staining with MoAb 439-9B 
in intact control skin, showing the presence of the extracellular integrin P4 epitope in a continuous linear pattern at the epidermal basement membrane zone 
(EBMZ) and at the borders of basal keratinocytes. Note that the P4 epitope is also faintly present in subepidermal bloodvessel walls. (B) Triple IF staining for 
the samep4 epitope (green), GB3-antigen (red), and laminill (blue) in NaCI-splitcontrol skin (blister cavity marked by asterisks), showing the green fluorescent 
P4 epitope in the blister roof. The patchy P4 staining pattern is induced by 1.0 M NaCI incubation (compare with A). Both laminin and GB3 are localized in the 
blister floor, yielding the purple-pink staining pattern as a result of superposition of blue fluorescent laminin and red fluorescent GB3. Note that overlap of all 
three fluorescent markers along the intact EBMZ at the lateral borders of the specimen results in a white color. The ultimate specificity of the triple 
immunostaining can be judged from the blue fluorescent laminin in subepidermal blood vessel walls that lack the GB3 antigen. The luminal site of these vessel 
walls additionally show faint expression of the P4 epitope, resulting in a mixture of blue and green fluorescence. Magnification X500. 
keratinocytes in a finely speckled or continuous pattern (Fig lA). 
This intercellular expression of integrin epitopes varied between 
specimens and with the type of MoAb used. Furthermore, MoAb 
against the intracellular part of the P4 subunit (450-11A, 450-10D) 
produced granular cytoplasmic staining of weak intensity in focal 
clusters of basal keratinocytes. 
Linear staining of a6p4 was also found with varying intensity 
along the BMZ of epidermal appendices (hair follicles, sebaceous 
glands, sweat glands, and ducts) and that of some blood vessels, but 
not at the basement membranes of the mm. arrectores pili. Periph-
eral nerves, in particular nerve endings associated with mm. arrec-
tores pili and Vater-Pacinian corpuscles, were also stained to various 
degrees by anti-a6 and -P4 MoAb. The GB3 antibody stained the 
EBMZ in a broad continuous linear pattern. In addition, GB3 
stained the basement membranes of sweat glands and sebaceous 
glands, but not those of blood vessels. 
In salt-split skin, MoAb to the intracellular P4 epitopes exclu-
sively stained the blister roof, whereas MoAb against the extracellu-
lar a6 or P4 epitopes additionally produced fine speckles in the 
blister floor, indicating that the salt-induced split occurred just be-
neath the integrin. After NaCI incubation, staining for a6p4 was 
irregular and patchy (Fig lB), which has recently also been reported 
by Michalaki et al [35J. In triple-staining experiments on salt-split 
skin, the a6p4 epitopes were localized predominantly in the roof of 
the blister, whereas laminin and GB3 were found exclusively in the 
blister floor (Fig lB). Using the dual-band FITC/TXR filter block, 
we observed that the in non-split areas of the EBMZ the green 
fluorescent extracellular P4 epitope was clearly localized above 
Figure 2. Single IF staining for integrinp4 subunit (MoAb 450-11A) in cryosections of normal skin from (A) a healthy human control and from (B,G) lethal 
JEB patients 2 and 1, respectively. The cell nuclei were counterstained with the blue fluorescent DNA marker bisbenzimide. (A) Usual linear staining pattern 
of (a6)p4 at the EBMZ in control skin. (B,G) In apparently healthy skin from the lethal JEB patients, the P4 staining pattern is interrupted at the borders of 
adjoining basal keratinocytes yielding a "stitchy" linear pattern. (G) The skin of patient 1 additionally shows focal cytoplasmic expression of the P4 subunit in 
basal keratinocytes. Magnification X500. 
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Table II. IF-Staining Characteristics of the MoAb Against 
Integrin cx.6P4 and Nicein in Skin of Patients with Junctional and 
Dystrophic Epidermolysis Bullosa and of Healthy Human Controls 
MoAb Patient (number) CYT' ICSb EBMZ' 
450-11A (/14) Junctional, lethal (1) +J +if 
Junctional, lethal (2) ±g +i 
Junctional, non-lethal (3) + 
Dystrophic, dominant (4) ± + 
Dystrophic, recessive (5) ± +s' 
Normal controls (n = 3) ± + 
450-10D (/14) Junctional, lethal (1) + +i 
Junctional, lethal (2) ± +i 
Junctional, non-lethal (3) + 
Dystrophic, dominant (4) + 
Dystrophic, recessive (S) + +s 
Normal controls (n = 3) ± + 
439-9B (/14) Junctional, lethal (1) + +i 
Junctional, lethal (2) + +i 
Junctional, non-lethal (3) + 
Dystrophic, dominant (4) + 
Dystrophic, recessive (5) +s 
Normal controls (n = 3) ± + + 
450-30D (a6) Junctional, lethal (1) ± +i 
Junctional, lethal (2) + +i 
Junctional, non-lethal (3) + + 
Dystrophic, dominant (4) + + 
Dystrophic, recessive (5) + +s 
Normal controls (n = 3) + + 
GoH3 (a6) Junctional, lethal (1) ± +i 
Junctional, lethal (2) ± +i 
Junctional, non-lethal (3) ± + 
Dystrophic, dominant (4) ± + 
. Dystrophic, recessive (5) ± +s 
Normal controls (n = 3) + + 
GB3 (Nicein) Junctional, lethal (1) 
Junctional, lethal (2) 
Junctional, non-lethal (3) + 
Dystrophic, dominant (4) + 
Dystrophic, recessive (5) +s 
Normal controls (n = 3) + 
• CYT, cytoplasmic staining of keratinocytes. 
• ICS, intercellular staining of keratinocytes. 
, EBMZ: epidermal basement membrane zone of intact skin. 
I +, clearly present (EBMZ, continuous linear) staining. 
t -, no staining. 
J +i, interrupted linear staining along EBMZ. 
g ±, reduced staining. 
, +s, smooth and thin continuous linear staining along EBMZ. 
(epidermal site) the blue fluorescent laminin and red fluorescent 
GB3. 
IF ofEB Skin There was no staining with GB3 antibody in the 
skin of the two/atients with lethal JEB (patients 1 and 2), but 
staining afpeare to be normal in the skin from the patient with 
non-letha JEB (patient 3) (Table II). Staining with MoAb against 
the cx.6 and P4 epitopes produced a continuous linear pattern at 
the EBMZ in all EB patients similar to that in control skin speci-
mens, except for the two patients with lethal JEB (patients 1 and 2) 
(Fig 2A - C). In these latter two patients the linear IF pattern of the 
cx.6 and P4 subunits was interrupted discontinuous-in patient 2 
more clearly than in patient l-yielding a "stitchy" pattern with 
small interruptions at regular intervals corresponding with the 
boundaries of adjoining basal keratinocytes (Fig 2B). Examination 
of serial sections showed that this "stitchy" pattern had a focal 
distribution and was more distinct at the BMZ of hair follicles. Also 
the staining pattern ofBPA was "stitchy" along the EBMZ in skin 
of the two patients with lethal JEB (data not shown), whereas the 
pattern of laminin was normally continuous. In addition, the P4 
subunit was markedly expressed in a fine granular cytoplarnic pat-
tern in focal basal keratinocytes of the skin from the patients with 
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Figure 3. Single IF staining of (A) extracellular integrin a6 (GoH3) epi-
tope and (B) intracellular /14 (4S0-11A) epitope in serial cryosections of 
normal skin from lethal JEB patient 2, showing a tiny blister (asterisk) at the 
follicular BMZ. (A) The extracellular a6 epitope is mainly expressed in the 
blister floor (arrowheaJ), whereas in the adjacent section (B) the intracellular 
/14 epitope is mainly localized in the blister roof (arrow). Magnification 
X500. 
lethal JEB (Fig 2C). Such an aberrant integrin pattern was not found 
in the other EB patients. Specifically, cx.6P4, BPA, and GB3 were 
normally expressed in the skin from the patient with non-lethal 
JEB. 
In the clinically uninvolved skin samples from the two lethal JEB 
patients, tiny blisters were noticed at the BMZ of hair follicles. In 
these tiny blisters, the extracellular cx.6P4 epitopes predominantlx 
lined the blister floor, whereas the intracellular epitopes predo!ll1-
nantly remained in the blister roof (Fig 3A - B). The cx.6P4 epitopes 
lost their antigenicity in older bullae, irrespective of the split level as 
we observed in biopsies from lesional skin of dystrophic and junc-
tional EB patients. Loss of cx.6P4 antigenicity has also been observed 
in bullae of patients with bullous pemphigoid by Michalaki et ~l; 
according to these authors this differentiates bullous pemphigOId 
from epidermolysis bullosa acquisita [35]. 
In patient 5, with recessive generalized EB, the IF pattern alo~g 
the EBMZ appeared as a smooth and thin line, differing from that In 
control· skin and the other EB skin specimens. This smooth IF pat-
tern was observed with both the anti-cx.6p4 and GB3 MoAb, as well 
as with anti-Iaminin, anti-collagen IV, and anti-collagen VII (L!'l 
7:2) antibodies. Electron microscopy of clinically uninvolved skin 
of this patient showed reduced keratinocyte projections with loss of 
anchoring fibrils resulting in a more stretched, less folded basement 
membrane (data not shown). 
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Figure 4. Transmission electron microscopy showing the basement mem-
brane zone of two adjoining basal keratinocytes in (A) a healthy human 
control and in (B) a patient with lethal lEB (patient 2). (A) Keratinocytes 
touch each other by interdigitating lamellipodia. The basal keratinocytes 
anchor to the basement membrane through intermediate tonofilaments 
(arrow) and hemidesmosomes (arrowheads), also present in the ultimate basal 
lamellipodium. (B) The basal lamellipodium (arrow) in lethal lEB skin al-
most completely lacks intermediate tonofilaments and hemidesmosomes. 
Bar,lllm. 
EM of Lethal JEB and Normal Human Skin In uninvolved 
skin from the two patients with lethal JEB a decreased number of 
hemidesmosomes was noticed in the electron microscope. The re-
maining hemidesmosomes had a smaller attachment plaque and 
lacked the sub-basal dense plate. In the basal keratinocytes a decrease 
of intermediate filaments (tonofilaments) was noticed, in particular 
of those projecting towards the inferior pole. These cytoskeletal 
abnormalities were most pronounced at the periphery of the inferior 
pole, at the boundary of adjoining basal keratinocytes. Basal kerati-
nocytes normally adjoin at the basement membrane by lamellipodia 
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(Fig 4A). In the skin from the lethalJEB patients these lamellipodia 
almost completely lacked hemidesmosomes and were also devoid of 
cytoskeletal structures such as intermediate (keratin) filaments (Fig 
4B). Anchoring filaments, lamina lucida, lamina densa, and anchor-
ing fibrils, however, all appeared structurally normal. 
!EM ofLethalJEB and Normal Human Skin P4 (450-10D) 
was expressed on the basal surface along the EBMZ. It was preferen-
tially confined to hemidesmosome-like structures, which occur 
more irregularly in JEB skin. In lethal JEB skin the lamellipodia at 
the cellular boundaries of basal keratinocytes had detached from the 
lamina densa. At that point the staining for p4 was interrupted (Fig 
SB). This peripheral cell detachment and P4 interruption was not 
observed in healthy human control skin (Fig SA). 
DISCUSSION 
In this study we found that the distribution pattern of the integrin 
a6p4 and BP A was abnormal along the EBMZ, coinciding with the 
complete absence of the GB3 antigen in patients with lethal JEB. 
Specifically, IF staining for the a6 andp4 epitopes and BPA was not 
continuous along the EBMZ, but was interrupted at the boundary of 
adjoining basal keratinocytes. !EM revealed that the interruptions in 
the integrin staining patterns in these patients were caused by focal 
tissue damage at the ultimate baso-Iateral edge of adjoining basal 
keratinocytes. The tissue damage appears to be caused by freezing 
and thawing, which was used for IF and !EM preparation, because it 
was absent in routine EM and non-frozen, fixed tissue samples of 
uninvolved JEB skin. EM revealed that the basallarnellipodia along 
the EBMZ at the point where basal keratinocytes meet almost com-
pletely lacked cytoskeletal elements and hemidesmosome-like 
structures. It thus appears that the adherence ofkeratinocytes in JEE 
patients who lack expression of GB3 (BM600 /nicein) is weakest to 
the basement membrane at the cell periphery. 
In the skin of the patient with the non-lethal type of JEB (patient 
3), a6p4 was expressed in a normal continuous linear pattern. The 
expression of GB3 was also normal in 40% of patients with non-
lethal JEB [36]. The overall fluorescence intensity of a6p4 and 
BPA in both the patients with lethal and the patient with non-lethal 
JEB in our study was not reduced, despite the decreased number 
and abnormal structure of hemidesmosomes. It is known from 
studies of cultured keratinocytes that hemidesmosomal antigens 
might be expressed in the absence of assembled hemidesmosomes 
[19 ,37]. 
In previous IF studies, Nazzaro et al found no significant alter-
ation in the intensity or distribution pattern of the a3 and a6 sub-
units stained with MoAb in clinically uninvolved skin of patients 
with JEB [23] . The expression of the P4 subunit was not investi-
gated. Fine et al reported a normal expression of a6p4 in a series of 
over 60 JEB patients [26]. Our preliminary study confirms the over-
all unreduced staining intensity of a6p4 in JEB skin. 
The positive expression of both the integrin a6p4 and BP A sug-
gests that neither are primarily defective in JEB. The abnormal 
hemidesmosomes avoiding the lateral edge of the basal surface of 
basal keratinocytes suggest another factor that interacts with hemi-
desmosome assembly. Recently, Krueger et al showed that cultured 
keratinocytes from patients with non-lethal JEB had a disorganized 
actin cytoskeleton, lacking focal contacts in the lamellipodia at the 
lateral edge of the substrate-associated cell surface [38J . BPA was 
confined to the central areas of the substrate-associated cell surface 
corresponding with immature hemidesmosome-like structures. 
Carter et al found that adherence of cultured keratinocytes to the 
substrate by focal contacts is mediated by the integrin a3pl adhe-
sion receptor, encircling a6p4 containing hemidesmosome-like 
structures [39]. It has recently been claimed that epiligrin is the 
putative ligand of a3pl and it appears to locate underneath adhesion 
complexes composed of a3pl focal contacts and a6p4 hemidesmo-
some-like structures [39] . In vivo, basal keratinocytes might, as in 
the in vitro situation, adhere to the basement membrane by focal 
contacts at the cell periphery. The multiple molecular targets re-
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Figure 5. Immunoelectron microscopic detection of P4 (450-100) in the 
basement membrane zone of two adjoining basal keratinocytes in (A) a 
healthy human control and in (B) a patient with lethal JEB (patient 2). (A) 
The reaction product is present in a discontinuous hemidesmosome-asso-
ciated linear distribution pattern along the basal surface of keratinocytes. 
Some tissue damage is present between the keratinocytes (asterisks) due to 
freezing, but the lame IIi podium at the basal boundary remains attached to 
the lamina densa.(arrows). The morphology of the areas between (arrowheads) 
hemidesmosomes has suffered from freezing and thawing. (B) The reaction 
product is interrupted along the basement membrane between keratinocytes. 
The adjoining basallamellipodia have been disrupted (bar) from the lamina 
densa due to freezing and thawing. The lamina densa has remained intact 
(arrows). Bar, 1 p.m. 
sponsible for keratinocyte adhesion might explain the clinical and 
morphologic heterogeneity in the JEB subgroup [1] . 
The split found along the basement membrane zone of hair folli-
cles in patients with lethal JEB separated the extracellular from the 
intracellular a6/34 epitopes, apparently dividing the integrin. In 
contrast, the split in NaCI-incubated skin from healthy human con-
trols almost completely occurred beneath all the a6{34 epitopes, as 
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also found by others [23,35]. It thus appears that the spontaneous 
split in JEB skin is localized more towards the cell membrane of the 
keratinocyte than the split induced by N aCI-incubation of healthy 
human control skin, suggesting a defect in the a6{34 itself or perhaps 
of its ligand. 
A possible molecular abnormality in JEB might be the abse.nce. of 
the ligand for the integrin a6/34 or another important entity lll-
volved in the integrin-ligand interaction. The {34 subunit is focally 
overexpressed in the cytoplasm of basal keratinocytes of patients 
with lethal JEB, which might be the result of retention or overpro-
duction of the receptor because of a lack of the extracellular ligan~. 
The extracellular ligand for the a6{34 receptor has not been identi-
fied, but it probably is a protein of the basement membrane .. In 
contrast to most integrins, a6{34 appears to recognize a bind~ng 
sequence in its extracellular ligand that is different from the classlc~l 
Arg-Gly-Asp (RGD) [21]. One possible explanation for the coinc~­
de nee of the absence of GB3 with an altered distribution of a6/34 IS 
that the antigen (nice in) recognized by GB3 is the ligand for a6/34. 
Verrando et al hypothized that nicein might be an iso-Iaminin be-
cause of its discrete homologies with laminin [40]. In the same 
respect, a6{34 might be the receptor for an iso-Iaminin, although 
a6{34 does not bind to either mouse laminin fragment E8 or hum~n 
laminin affinity columns, as the classicallaminin receptor inte?nn 
a6{31 does in many different cell types [41,42] . The tissue distri.bu-
tion of GB3 [33] (skin, larynx, esophagus, stomach, small intestine, 
colon, bladder, pancreas) is similar to that of the {34 subunit [43], 
except that the latter is also found in bloodvessels ([44] , this study]) 
and in peripheral nerves ([43] , this study). However, multiple forms 
of {34 may exist, fosSibly due to cell-type specific alternative mRNA 
splicing [45 -47 . Further support for the possible relation between 
GB3 and {34 is that neither occur in melanocytes [21 ,33,48]. HoW-
ever, evidence for a direct interaction between a6{34 and nicein has 
to be determined. Other possible ligands for a6{34 are 19-DEJ-l [4], 
125 kD mABHD [37]' 1-2B7B [49], or the recently identified p~o­
teins kalinin [50] and epiligrin [39], which all preferentially localize 
below the sub-basal dense plate of hemidesmosomes. 
The results of this preliminary study of two patients with lethal 
JEB need further confirmation in other patients. Immunohisto~he­
mical studies of cultured JEB keratinocytes may also shed more hght 
on the relationship between abnormal adhesion, lack ofligands, a~d 
redistribution of hemidesmosomes in this hereditary bullous diS-
order. 
We conclude that the expression of the integrin a6{34 and ofBP.A 
is unreduced in junctional and dystrophic EB. However, in s.klll 
from patients with lethal JEB, who lack expression of GB3, I~­
munohistochemical staining of integrin a6{34 and BPA is lll-
terrupted at the peripheral border of basal keratinocytes due to 
freeze induced partial cell detachment from the basement mem-
brane. 
We wish to thatlk Dr. S. Bruins Jor his technical support in triple IF microscopy and 
Mr. H. de Weerd Jor his assistance ill electron microcopy. Dr. P. EtlgelJriet is thanked 
Jor critical reading oj the manuscript. 
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